Ascendis Pharma (ASND)
(Real Time Quote from BATS)
$121.27 USD
+0.15 (0.12%)
Updated May 20, 2024 03:24 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Brokerage Reports
Ascendis Pharma A/S [ASND]
Reports for Purchase
Showing records 41 - 60 ( 303 total )
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
SKYTROFA Unfazed by the Once-Weekly GH Competition; Focus Remains on TC-PTH/HP
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
ENDO 2023: Impressive 52wk Ph3 PaTHway Results for TCPTH/ HP; TC-hGH Update
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
TC-PTH Compassionate Use Program Opened in Germany; Potential EU Approval in Q4
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Focusing in on TC-IL-2â/ã At Oncology RD Day Ahead of ASCO
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A